Harrow, Inc. (HROW)
52.00
+1.18
(+2.32%)
USD |
NASDAQ |
Feb 20, 16:00
52.03
+0.03
(+0.06%)
After-Hours: 20:00
Harrow SG&A Expense (Quarterly) : 35.86M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 123.98M |
| Assertio Holdings, Inc. | 10.74M |
| CapsoVision, Inc. | 3.843M |
| ACADIA Pharmaceuticals, Inc. | 133.40M |
| Alnylam Pharmaceuticals, Inc. | 325.37M |